Diligence memo · auto-generated · as of July 2, 2026
Twenty30 Health, Inc.
Twenty30 Health, Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Twenty30 Health, Inc. operates in Healthtech, based in PHILADELPHIA.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Twenty30 Health, Inc. has raised $8.4M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $5.2M on 2023-09-15.
Most recent recorded round closed around 2024-06-07.
Valuation (modeled)modeled
Provath models Twenty30 Health, Inc. at approximately $9.6M (range $2.4M–$21M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.23× the median modeled value of Series A Healthtech companies in 2022–2024 (190 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 4 months.
Last raise 2.1 yr ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round was 2.8× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 66% of Healthtech peers (2138 compared).
Modeled value ranks above 32% of those peers.
Closest niche peers: Nayya Health, Inc., Nue Life Health Inc., W Health Studio, Inc., Avant-garde Health, Inc., Kinetik Healthcare Solutions, Inc.
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.